Press Release

TriSalus Life Sciences Completes Merger With MedTech Acquisition Corporation

August 16, 2023

San Diego – August 16, 2023 – Cooley advised TriSalus Life Sciences, an oncology company with a focus on treatments for patients with liver and pancreatic tumors, on its merger with MedTech Acquisition Corporation. Partners Matthew Browne, Rama Padmanabhan and Rupa Briggs – along with associates Rajdeep Bains, Alexander Gefter, Brett Dovman, Jayden Martinez and Pitrina Gilger – led the Cooley team advising TriSalus.

The merger will advance TriSalus’ technology development and sales growth, as well as move SD-101 – an investigational immunotherapeutic designed to improve patient outcomes by treating the immunosuppressive environment created by tumors – into phase 2 clinical trial and provide cash runway through mid-2024 to fund key milestones.

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.

Cooley has nearly 1,400 lawyers across 18 offices in the United States, Asia and Europe, and a total workforce of more than 3,000.

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.